l carnitine tmao koeth 2013 nature medicine Dietary allicin reduces transformation of L-carnitine to through impact on gut microbiota γ-Butyrobetaine Is a Proatherogenic Intermediate
Butyrobetaine Is a Proatherogenic Intermediate in Gut Microbial Metabolism of L Carnitine to TMAO ScienceDirect A Multi omic Association Study of Trimethylamine N Oxide ScienceDirect Innovative carnitine fed rats model reveals resveratrol butyrate Ester's multimechanistic role in reducing TMAO and cardiovascular risk ScienceDirect Gut microbiota metabolism of l carnitine and cardiovascular risk Atherosclerosis Gut Derived Metabolite, Trimethylamine N oxide (TMAO) in Cardio Metabolic Diseases: Detection, Mechanism, and Potential Therapeutics
Pay in 4 interest-free payments of $7.39 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10




